Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ACCD - Accolade, Inc.
Market Cap 1.09B P/E - EPS this Y 18.00% Ern Qtrly Grth -
Income -88.99M Forward P/E -10.21 EPS next Y 12.80% 50D Avg Chg 10.00%
Sales 431.53M PEG 3.93 EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 2.39 EPS next 5Y -0.90% 52W High Chg -15.00%
Recommedations 1.90 Quick Ratio 2.62 Shares Outstanding 80.01M 52W Low Chg 111.00%
Insider Own 3.12% ROA -7.89% Shares Float 72.15M Beta 2.00
Inst Own 83.39% ROE -20.01% Shares Shorted/Prior 4.53M/3.86M Price 14.40
Gross Margin 47.49% Profit Margin -20.62% Avg. Volume 646,991 Target Price 7.89
Oper. Margin -26.30% Earnings Date Oct 8 Volume 408,999 Change -3.87%
Healthcare | Health Information Services | United States
About Accolade, Inc.

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Accolade, Inc. News
11/13/24 Accolade To Present at Upcoming Investor Conferences
10/31/24 Accolade And 2 Other Penny Stocks To Watch On US Exchanges
10/24/24 Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10/15/24 Accolade Welcomes Renalogic to Trusted Partner Ecosystem
10/10/24 Accolade (ACCD) Upgraded to Buy: Here's What You Should Know
10/09/24 Accolade Second Quarter 2025 Earnings: Beats Expectations
10/09/24 Accolade Inc (ACCD) Q2 2025 Earnings Call Transcript Highlights: Strong Revenue and Cash Flow ...
10/08/24 Q2 2025 Accolade Inc Earnings Call
10/08/24 Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
10/08/24 Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
10/08/24 Accolade shares soar on narrower quarterly loss, margin growth
10/08/24 Accolade: Fiscal Q2 Earnings Snapshot
10/08/24 Accolade Announces Results for Fiscal Second Quarter 2025
09/18/24 With 74% ownership, Accolade, Inc. (NASDAQ:ACCD) boasts of strong institutional backing
09/18/24 Accolade to Announce Fiscal Second Quarter 2025 Financial Results
09/12/24 One of the largest blockchain fund of funds has raised over $135 million across two new vehicles
08/30/24 All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy
08/28/24 Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
08/22/24 First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies
08/07/24 Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
ACCD Chatroom

User Image TheLearnerEarner Posted - 1 week ago

$ACCD great 18%+ gains so far with this SWING TRADE idea 📈 FOLLOW to be in 1st 🏆 always FREE trade idea alerts on Stocktwits only! 📟

User Image insiderbuyingselling Posted - 2 weeks ago

$ACCD new insider selling: 475 shares. http://insiderbuyingselling.com/?t=ACCD

User Image insiderbuyingselling Posted - 2 weeks ago

$ACCD new insider selling: 1545 shares. http://insiderbuyingselling.com/?t=ACCD

User Image stockandsex Posted - 2 weeks ago

$ACCD

User Image PenkeTrading Posted - 10/24/24

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Accolade Inc. Is that bullish or bearish? $ACCD #RsiOversold #NASDAQ

User Image TheLearnerEarner Posted - 10/24/24

$ACCD ✅ UNDERVALUED stock swing trade - healthcare - small cap - 6/9 F-Score - 0.80x relative volume - 1x analysts buy rating - excellent intrinsic value potential - revenue is forecast to grow 11% per year - trading at 93% below estimate of its fair value - short to medium term gains 📈 RSI: 30.41 (oversold bullish) 📊🐂 Analysts Price Target: $7.08 - $12.00 (121.25% - 268.66% above Price) 🌟 Range (12m) $3.17 - $15.36 💰 NEWSDESK (last recent article) 📰 https://www.stocktitan.net/news/ACCD/accolade-welcomes-renalogic-to-trusted-partner-golfyjdbmxu5.html

User Image stockandsex Posted - 10/24/24

$ACCD

User Image sager1962 Posted - 10/23/24

$ACCD Hello, advice please, is this price suitable for buying or waiting? The purchase is my responsibility. Thank you.

User Image EarningsCentral Posted - 10/23/24

$ACCD Earnings Call Recap for Q2 2025 https://youtu.be/XHhW5agXZb0

User Image stockandsex Posted - 10/22/24

$ACCD whoever didn’t sell over $4 now can buy more @$2🤪🤣

User Image stockandsex Posted - 1 month ago

$ACCD

User Image SerbianSU Posted - 1 month ago

$ACCD lol...bought it @3.61...not good...bought @3.51...apparently not good either. Ok...I guess 3.41?

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 385 shares. http://insiderbuyingselling.com/?t=ACCD

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 157 shares. http://insiderbuyingselling.com/?t=ACCD

User Image Kwest4106 Posted - 1 month ago

@SerbianSU @runkerad which one moves up first? $ACCD has been following the same movements.

User Image Kwest4106 Posted - 1 month ago

$ACCD holding it down, $3.74. Push it up already.

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 228 shares. http://insiderbuyingselling.com/?t=ACCD

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 680 shares. http://insiderbuyingselling.com/?t=ACCD

User Image stockandsex Posted - 1 month ago

$ACCD $2 next waiting for swing trading again in 30 days timeframe

User Image Kwest4106 Posted - 1 month ago

$ACCD $SPY Yes I hold the position. Buy it, don’t buy it. BUT $5 Call for 12-19-25 is under 1.00 right now and That just seems super undervalued to me. Check it out, tell me what you think.

User Image Kwest4106 Posted - 1 month ago

$ACCD Run to $5 in the up coming weeks but damn they are holding $3.71-$3.73 tight right now.

User Image MambaMentality077 Posted - 1 month ago

$ACCD I want out of this POS

User Image Kwest4106 Posted - 1 month ago

Bought $6 & $7 Calls yesterday for $NOVA Nice return but hoping for a bigger push up. $ACCD you’re next, let’s go.

User Image Bromberger Posted - 1 month ago

$ACCD nice close 🐂

User Image FilingFact Posted - 1 month ago

$ACCD According to https://www.filingfact.com these are some of the top facts from the last report: Positive Facts - Revenue increased $9.5 million, or 10%, to $106.4 million for the three months ended August 31, 2024, as compared to $96.9 million for the three months ended August 31, 2023 - Revenue increased $26.7 million, or 14%, to $216.8 million for the six months ended August 31, 2024, as compared to $190.1 million for the six months ended August 31, 2023 - Revenue from usage-based fees increased $7.7 million, or 30%, to $33.7 million for the three months ended August 31, 2024 as compared to $26.0 million for the three months ended August 31, 2023 - Revenue from usage-based fees increased $14.6 million, or 28%, to $67.2 million for the six months ended August 31, 2024 as compared to $52.6 million for the six months ended August 31, 2023 Negative Facts - No top negative facts

User Image Dollarmaker777 Posted - 1 month ago

$ACCD volumes continue to come in now

User Image simonc86 Posted - 1 month ago

$ACCD lol

User Image anachartanalyst Posted - 1 month ago

https://anachart.com/market-update/october-10th-2024/ $ACCD $AFRM $SAGE

User Image IN0V8 Posted - 1 month ago

$ACCD Barclays cuts target price to $5 from $5.50 Canaccord Genuity cuts target price to $7 from $13 Stephens cuts target price to $8 from $10 Truist Securities cuts target price to $7.50 from $9

User Image VaingloryInvestor Posted - 1 month ago

$ACCD. In.

Analyst Ratings
Guggenheim Buy Jun 28, 24
Stifel Buy Jun 28, 24
Truist Securities Buy Jun 28, 24
Morgan Stanley Equal-Weight Jun 28, 24
Barclays Equal-Weight Jun 28, 24
Canaccord Genuity Buy Jun 28, 24
Needham Buy Jun 28, 24
Needham Buy Jun 24, 24
Guggenheim Buy May 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Eskew Richard EVP General Counsel EVP General Counsel Feb 01 Sell 11.59 562 6,514 37,195 02/05/24
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Feb 01 Sell 11.59 424 4,914 35,426 02/05/24
Eskew Richard EVP General Counsel EVP General Counsel Jan 19 Sell 11.99 400 4,796 36,119 01/22/24
Cavanaugh Robert N President President Jan 16 Sell 12.86 186 2,392 170,086 01/18/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 16 Sell 12.86 383 4,925 742,711 01/18/24
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jan 16 Sell 12.86 146 1,878 176,102 01/18/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 15.02 21,530 323,381 742,162 01/12/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 11 Option 4.2 21,530 90,426 763,692 01/12/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 10 Sell 14.75 770 11,358 742,162 01/12/24
Cavanaugh Robert N President President Jan 10 Sell 14.75 255 3,761 169,762 01/12/24
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jan 10 Sell 14.75 267 3,938 175,833 01/12/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 09 Option 4.2 103,470 434,574 808,553 01/11/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 09 Sell 15.02 103,470 1,554,119 741,282 01/11/24
Eskew Richard EVP General Counsel EVP General Counsel Jan 02 Sell 11.4 590 6,726 36,519 01/04/24
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Jan 02 Sell 11.4 446 5,084 34,617 01/04/24
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Dec 18 Sell 10.89 116 1,263 175,330 12/20/23
Cavanaugh Robert N President President Dec 18 Sell 10.89 151 1,644 169,307 12/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Dec 18 Sell 10.89 366 3,986 741,282 12/20/23
Eskew Richard EVP General Counsel EVP General Counsel Dec 19 Sell 10.76 400 4,304 35,470 12/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Dec 11 Sell 9.23 677 6,249 740,715 12/13/23
Cavanaugh Robert N President President Nov 16 Sell 7.94 149 1,183 168,086 11/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Nov 16 Sell 7.94 358 2,843 739,742 11/20/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Nov 16 Sell 7.94 114 905 145,713 11/20/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Nov 10 Sell 6.99 223 1,559 145,413 11/14/23
Cavanaugh Robert N President President Nov 10 Sell 6.99 217 1,517 167,724 11/14/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Nov 10 Sell 6.99 666 4,655 739,166 11/14/23
Eskew Richard EVP General Counsel EVP General Counsel Nov 01 Sell 6.88 456 3,137 33,932 11/03/23
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Nov 01 Sell 6.88 345 2,374 32,952 11/03/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Oct 16 Sell 7.22 118 852 144,866 10/18/23
Cavanaugh Robert N President President Oct 16 Sell 7.22 153 1,105 167,231 10/18/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Oct 16 Sell 7.22 371 2,679 588,183 10/18/23
Cavanaugh Robert N President President Sep 18 Sell 11.81 157 1,854 166,378 09/20/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Sep 18 Sell 11.81 121 1,429 144,019 09/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Sep 18 Sell 11.81 378 4,464 586,630 09/20/23
Eskew Richard EVP General Counsel EVP General Counsel Sep 01 Sell 13.53 475 6,427 31,596 09/06/23
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Sep 01 Sell 13.53 358 4,844 31,199 09/06/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Aug 17 Sell 13.03 121 1,577 143,177 08/21/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Aug 17 Sell 13.03 377 4,912 585,087 08/21/23
Cavanaugh Robert N President President Aug 17 Sell 13.03 157 2,046 165,529 08/21/23
Eskew Richard EVP General Counsel EVP General Counsel Aug 01 Sell 14.37 489 7,027 30,432 08/03/23
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Aug 01 Sell 14.37 370 5,317 30,325 08/03/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jul 17 Sell 14.16 117 1,657 142,336 07/19/23
Cavanaugh Robert N President President Jul 17 Sell 14.16 152 2,152 164,683 07/19/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jul 17 Sell 14.16 364 5,154 583,538 07/19/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jul 10 Sell 12.68 655 8,305 582,970 07/12/23
Cavanaugh Robert N President President Jul 10 Sell 12.68 216 2,739 164,325 07/12/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jul 10 Sell 12.68 222 2,815 142,039 07/12/23
Eskew Richard EVP General Counsel EVP General Counsel Jul 03 Sell 12 515 6,180 29,282 07/06/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jun 12 Sell 13.81 2,576 35,575 141,197 06/14/23
Cavanaugh Robert N President President Jun 12 Sell 13.81 2,511 34,677 163,478 06/14/23